Loading...
Ceftazidime — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Ceftazidime
2025-Q4
Comprehensive analysis of India’s ceftazidime export trade — suppliers, buyers, prices, routes, and every shipment record.
121
Shipments
$1.53M
Trade Value
53
Suppliers
45
Buyers
41
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/ceftazidime
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s ceftazidime trade — 2025-Q4
KEY TAKEAWAY
Ceftazidime 2025-Q4 exports total $1.5M across 41 countries, with VENUS REMEDIES LTD commanding 12.1% market share.
TOTAL SHIPMENTS
121
2025-Q4
EXPORT VALUE
$1.5M
FOB USD
TOTAL QUANTITY
2.6M
units shipped
INDIAN SUPPLIERS
53
unique exporters
GLOBAL BUYERS
45
unique importers
DESTINATIONS
41
countries
MEDIAN UNIT PRICE
$0.615
per unit
TOP-5 SHARE
46.7%
of total USD
BRANDED SHARE
73.6%
89 shipments
DOSAGE FORMS
13
product types
6 KEY FINDINGS
1
VENUS REMEDIES LTD is India's #1 Ceftazidime exporter with $186.1K (12.1% market share).→ §5, Indian Supplier Rankings
2
Ceftazidime reached 41 countries, with Tajikistan as the top destination ($239.0K).→ §4, Global Destination Map
3
Market concentration is low (HHI: 656) — top 10 suppliers control 73.4% of exports.→ §5, Indian Supplier Rankings
4
91.1% of buyers (41 of 45) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Injection dominates (58.0%) across 13 dosage forms.→ §7, Price Benchmarks
6
40 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 VENUS REMEDIES LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian ceftazidime exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Ceftazidime report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial ceftazidime trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian ceftazidime suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Ceftazidime India trade report
Product scope
Ceftazidime
All variants merged — branded and generic formulations of ceftazidime
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
121
Every commercial ceftazidime trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $497.1K, Nov $687.0K, Dec $349.9K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$497.1K
Oct USD
28 shipments
2
$687.0K
Nov USD
+38.2% MoM
3
$349.9K
Dec USD
-49.1% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 38.2% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $497K, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $1.5M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $190K rise in Nov, $337K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $497K | 28 shipments |
| Nov | $687K | 45 shipments |
| Dec | $350K | 48 shipments |
| Q4 Total | $1.5M | 121 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: France held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: GALPHA LABORATORIES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import ceftazidime from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Tajikistan absorbs 15.6% of India’s 2025-Q4 ceftazidime trade ($239.0K). Beyond the top 10 destinations, 40 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 14 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 40 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much ceftazidime India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$693K
45.2% of trade
14 countries · 48 shipments
Europe
$365K
23.8% of trade
6 countries · 11 shipments
Americas
$62K
4.0% of trade
7 countries · 24 shipments
Africa
$413K
27.0% of trade
13 countries · 37 shipments
Oceania
$1K
0.1% of trade
1 countries · 1 shipments
Fig 4.1 Tajikistan is the #1 corridor ($239K) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian ceftazidime it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Tajikistan | $239K | 10 | EVOLET HEALTHCARE PVT LTD | $154K | GOGA HEALTHCARE | $46K | IND SWIFT LABORATORIES LTD | $22K |
| 2 | Hungary | $166K | 4 | VENUS REMEDIES LTD | $166K | — | — | — | — |
| 3 | Kenya | $165K | 7 | CHETAN & DIPTI (C&D) PHARMA PVT LTD | $92K | THEON PHARMACEUTICALS LTD | $73K | — | — |
| 4 | France | $152K | 3 | GALPHA LABORATORIES LTD | $152K | — | — | — | — |
| 5 | Kazakhstan | $103K | 2 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | $103K | — | — | — | — |
| 6 | Yemen | $94K | 1 | MANKIND PHARMA LTD | $94K | — | — | — | — |
| 7 | Thailand | $89K | 1 | SWISS PARENTERALS LTD | $89K | — | — | — | — |
| 8 | Nigeria | $83K | 3 | FINECURE PHARMACEUTICALS LTD | $60K | PROTECH BIO SYSTEMS PVT LTD | $23K | — | — |
| 9 | Sudan | $80K | 6 | INJECT CARE PARENTERALS PVT LTD | $79K | BAKER & DAVIS PVT LTD | $1K | INNOVA CAPTAB LTD | $582 |
| 10 | Venezuela | $59K | 13 | ALDE MEDI IMPEX LTD | $58K | EXQUISITE PHARMA LLP | $891 | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 45.2% of USD — but Tajikistan is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
15.6%
#1 country share
Tajikistan alone
53.8%
Top 5 share
5 of 41 countries
92.1%
Top 15 share
Long tail of 26 countries = 7.9%
HHI 800
Destination HHI
Competitive spread
41
Countries served
Global pharma reach from India
14
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
53 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
VENUS REMEDIES LTD ($186.1K, 12.1% share) and EVOLET HEALTHCARE PVT LTD ($153.6K) together control 22.1% of India’s 2025-Q4 ceftazidime trade. The top 5 suppliers hold 46.7%. 53 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian ceftazidime suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 VENUS REMEDIES LTD leads by $32K over EVOLET HEALTHCARE PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: UNITED BIOTECH PVT is #15 by value but #4 by volume.
Fig 5.2 VENUS REMEDIES LTD also leads by shipment count (17) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: UNITED BIOTECH PVT moves from #4 by volume to #15 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 53 ceftazidime suppliers split into strategic segments
KEY TAKEAWAY
14 suppliers (25%) generate 85.3% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 VENUS REMEDIES LTD and EVOLET HEALTHCARE PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 85.3% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | VENUS REMEDIES LTD | 6 | 5 | $186K |
| 2 | ALDE MEDI IMPEX LTD | 2 | 1 | $58K |
| 3 | EVOLET HEALTHCARE PVT LTD | 1 | 1 | $154K |
| 4 | GALPHA LABORATORIES LTD | 1 | 1 | $152K |
| 5 | MANKIND PHARMA LTD | 1 | 2 | $121K |
| 6 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | 1 | 1 | $103K |
| 7 | SWISS PARENTERALS LTD | 1 | 2 | $97K |
| 8 | CHETAN & DIPTI (C&D) PHARMA PVT LTD | 1 | 1 | $92K |
| 9 | THEON PHARMACEUTICALS LTD | 1 | 2 | $80K |
| 10 | INJECT CARE PARENTERALS PVT LTD | 1 | 1 | $79K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the ceftazidime manufacturing hubs
KEY TAKEAWAY
Gurgram and New Delhi together account for $283K of India’s 2025-Q4 ceftazidime trade.
Fig 5.5 Gurgram (1 exporters, $154K) and New Delhi (4 exporters, $129K) are India’s ceftazidime capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
46.7%
Top 5 share
5 of 53 suppliers
73.4%
Top 10 share
10 of 53 suppliers
85.3%
Top 25% share
14 suppliers = 85% USD
HHI 656
Supplier HHI
Competitive
53
Total suppliers
shipped Ceftazidime in 2025-Q4
20+ cities
Indian hubs
Gurgram and New Delhi lead
§5.2 Coming next: 2 exporter deep-dive profiles
Each of the top 2 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | VENUS REMEDIES LTD | $186K |
| #2 | THEON PHARMACEUTICALS LTD | $80K |
#1
EXPORTER PROFILE #1 OF 2
VENUS REMEDIES LTD
Behra · India’s #1 ceftazidime supplier by USD · 2025-Q4
2025-Q4 USD
$186K
12.1% market share
SHIPMENTS
17
avg $11K/ship
COUNTRIES
5
destination markets
BUYERS
6
5 single-sourced
BRANDED
47%
of shipments
DOSAGE FORMS
6
product types
TOP 5 DESTINATIONS
Hungary is the #1 market at $166K (89% of trade), followed by Saudi Arabia at $18K. 5 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Hungary | $166K | 4 | 89.3% |
| 2 | Saudi Arabia | $18K | 6 | 9.8% |
| 3 | Panama | $1K | 1 | 0.8% |
| 4 | Greece | $97 | 1 | 0.1% |
| 5 | Morocco | $9 | 5 | 0.0% |
MONTHLY TREND
Nov peaked at $176K. Dec was the weakest at $1K.
PRODUCT MIX
powder for solution for injection dominates at 82% of trade. powder_for_injection (14.3%) and Powder are secondary formulations.
TOP BUYERS · 5/5 LOCKED IN
5 of 5 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Saudi Arabia | $88K | N/A |
| E P H K | Hungary | $83K | ⚠ Locked |
| S T C | Saudi Arabia | $14K | ⚠ Locked |
| U P G | Panama | $1K | ⚠ Locked |
| QUALIMETRIX SA | Greece | $97 | ⚠ Locked |
| PHARMAPROM | Morocco | $8 | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 2 — TRADE FLOW MAP
VENUS REMEDIES LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 Hungary absorbs $166K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#8
EXPORTER PROFILE #2 OF 2
THEON PHARMACEUTICALS LTD
Distt Solan Hp · India’s #8 ceftazidime supplier by USD · 2025-Q4
2025-Q4 USD
$80K
5.2% market share
SHIPMENTS
7
avg $11K/ship
COUNTRIES
2
destination markets
BUYERS
2
1 single-sourced
BRANDED
100%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Kenya is the #1 market at $73K (91% of trade), followed by Philippines at $8K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Kenya | $73K | 6 | 90.5% |
| 2 | Philippines | $8K | 1 | 9.5% |
MONTHLY TREND
Oct peaked at $43K. Nov was the weakest at $0.
PRODUCT MIX
Injection dominates at 100% of trade.
TOP BUYERS · 1/1 LOCKED IN
1 of 1 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Kenya | $73K | N/A |
| GREEN CORE PHARMA INC | Philippines | $8K | ⚠ Locked |
#8
EXPORTER PROFILE #2 OF 2 — TRADE FLOW MAP
THEON PHARMACEUTICALS LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P2.3 Kenya absorbs $73K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
45 importers across 41 countries — who is buying Indian ceftazidime and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 63.2% of total USD. 91% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian ceftazidime. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 DUSTI PHARM LLC is the #1 importer at $154K (10.0%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
91%
Single-source
41 buyers rely on exactly 1 Indian supplier
4%
Dual-source
2 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
4%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source ceftazidime from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Afghanistan 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ZAHIR HADROGULL LTD | MANKIND PHARMA LTD | $27K | $0.270 | Injection |
| RAOUFI GLOBAL GROUP CO… | ZYDUS LIFESCIENCES LTD | $8K | $14.789 | powder for concentrate |
| MASEEH AMIRZAI LTD | PLICA VACCINES PVT LTD | $5K | $0.388 | Powder |
| MUSBAH TASNIM TRADING … | MODS DISPENSARY | $3K | $0.213 | Injection |
Philippines 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| GREEN CORE PHARMA INC | THEON PHARMACEUTICAL… | $8K | $0.760 | Injection |
| DELEX PHARMA INTERNATI… | UNITED BIOTECH PVT LTD | $6K | $1.142 | Injection |
| BRADY PHARMA INC | VHB MEDI SCIENCES LTD | $4K | $0.930 | Injection |
Tajikistan 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| DUSTI PHARM LLC | EVOLET HEALTHCARE PV… | $154K | $0.462 | Vial |
| LLC SHIFOI SINON. MAKH… | HEAL REMEDICS PVT LTD | $17K | $0.551 | Vial |
France 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PLANET PHARMA SA | GALPHA LABORATORIES … | $114K | $3.797 | Injection |
| PLANET PHARMAZONE DACT… | GALPHA LABORATORIES … | $38K | $3.783 | Injection |
Cambodia 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SAK CAM PHARMA CO LTD | UNITED BIOTECH PVT LTD | $6K | $0.649 | Injection |
| ZEE HEALTHCARE CAMBODI… | ZEE LABORATORIES LTD | $2K | $0.618 | Injection |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | DUSTI PHARM LLC | Tajikistan | $154K | $51K | Premium |
| 2 | PLANET PHARMA SA | France | $114K | $57K | Premium |
| 3 | M/S.AL MOATAMAD FOR … | Yemen | $94K | $94K | Premium |
| 4 | KAMCARE PHARMA LTD | Kenya | $92K | $92K | Premium |
| 5 | E P H K | Hungary | $83K | $42K | Premium |
| 6 | BIOGLASS PHARMACEUTI… | Venezuela | $58K | $5K | Budget |
| 7 | TOROPH | Kazakhstan | $52K | $52K | Premium |
| 8 | DISPHARMA COTE DIVOIRE | Cote d'Ivoire | $41K | $41K | Premium |
| 9 | SIA MAGNIPHARMA | Latvia | $38K | $38K | Premium |
| 10 | PLANET PHARMAZONE DA… | France | $38K | $38K | Premium |
| 11 | LIAONING SA | China | $30K | $30K | Mid |
| 12 | RESMED HEALTHCARE | South Africa | $28K | $14K | Budget |
| 13 | ZAHIR HADROGULL LTD | Afghanistan | $27K | $27K | Mid |
| 14 | LLC TIBBI OMEXTA | Tajikistan | $22K | $6K | Budget |
| 15 | LLC SHIFOI SINON. MA… | Tajikistan | $17K | $17K | Mid |
| 16 | S T C | Saudi Arabia | $14K | $3K | Budget |
| 17 | CHINARE ANI PHARMACE… | Nigeria | $12K | $12K | Budget |
| 18 | ATHAL INTERNATIONAL … | Libya | $11K | $11K | Budget |
| 19 | RAOUFI GLOBAL GROUP … | Afghanistan | $8K | $4K | Budget |
| 20 | GREEN CORE PHARMA INC | Philippines | $8K | $8K | Budget |
| 21 | SAK CAM PHARMA CO LTD | Cambodia | $6K | $6K | Budget |
| 22 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | $6K | $1K | Budget |
| 23 | DELEX PHARMA INTERNA… | Philippines | $6K | $6K | Budget |
| 24 | MASEEH AMIRZAI LTD | Afghanistan | $5K | $3K | Budget |
| 25 | KLINTAS PVT LTD | Sri Lanka | $5K | $5K | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 VENUS REMEDIES LTD → DUSTI PHARM LLC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian ceftazidime prices vary by supplier, country and dosage form
KEY TAKEAWAY
Ceftazidime prices span 174995× ($0.0002 → $35.96). The coefficient of variation is 2.36. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0002 | Lowest observed unit price |
| P5 | $0.0066 | 5th percentile |
| P25 | $0.374 | 25th percentile (Q1) |
| Median | $0.615 | 50th percentile (Q2) |
| P75 | $1.39 | 75th percentile (Q3) |
| P95 | $14.79 | 95th percentile |
| Max | $35.96 | Highest observed unit price |
| Mean | $2.94 | Arithmetic average |
| CV | 236% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 RMPL PHARMA LLP prices at $25.87/unit vs market median $0.615.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. EVOLET HEALTHCARE PVT Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. VENUS REMEDIES LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. CHETAN & DIPTI Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. GOGA HEALTHCARE Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | LEOWIN HEALTHCAR… | Azerbaijan | Powder | 4 | $1K | $324.63 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Azerbaijan | Other | 50 | $2K | $35.96 | Specialty / small-batch |
| Nov 2025 | RMPL PHARMA LLP | United Arab Emirates | Vial | 100 | $4K | $35.70 | Specialty / small-batch |
| Nov 2025 | RMPL PHARMA LLP | United Arab Emirates | Vial | 100 | $4K | $35.70 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Azerbaijan | Injection | 50 | $2K | $31.95 | Sterile formulation premium |
| Dec 2025 | SWISS PARENTERAL… | Albania | Injection | 500 | $8K | $16.32 | Sterile formulation premium |
| Dec 2025 | ZYDUS LIFESCIENC… | Afghanistan | powder for concentrate | 50 | $739.45 | $14.79 | Specialty / small-batch |
| Dec 2025 | ZYDUS LIFESCIENC… | Afghanistan | powder for concentrate | 500 | $7K | $14.79 | Specialty / small-batch |
| Oct 2025 | GOGA HEALTHCARE | Tajikistan | Injection | 3K | $46K | $14.69 | Sterile formulation premium |
| Nov 2025 | BDR PHARMACEUTIC… | Kazakhstan | Powder for Injection | 4K | $52K | $12.93 | Sterile formulation premium |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | VEA IMPEX (I) PV… | Somalia | Injection | 578 | $2.92 | $0.0050 | Sterile formulation premium |
| Dec 2025 | VEA IMPEX (I) PV… | Somalia | Injection | 422 | $2.13 | $0.0050 | Sterile formulation premium |
| Dec 2025 | THRIVE THERAPEUT… | Tajikistan | Injection | 8K | $49.41 | $0.0062 | Sterile formulation premium |
| Dec 2025 | INNOVA CAPTAB LTD | Sudan | Injection | 14K | $91.79 | $0.0065 | Sterile formulation premium |
| Dec 2025 | INNOVA CAPTAB LTD | Sudan | Injection | 76K | $490.00 | $0.0065 | Sterile formulation premium |
| Dec 2025 | VEA IMPEX (I) PV… | Somalia | Vial | 1K | $6.62 | $0.0066 | |
| Dec 2025 | VEA IMPEX (I) PV… | Somalia | Vial | 1K | $6.62 | $0.0066 | |
| Dec 2025 | VEA IMPEX (I) PV… | Somalia | Vial | 1K | $6.62 | $0.0066 | |
| Nov 2025 | VENUS REMEDIES LTD | Morocco | Powder | 60 | $1.37 | $0.023 | Small sample / trial shipment |
| Nov 2025 | VENUS REMEDIES LTD | Morocco | powder for solution | 60 | $1.38 | $0.023 | Small sample / trial shipment |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship ceftazidime, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Ceftazidime leaves India through 17+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), DELHI AIR, PIYALA ICD) handle 77.2% of total USD. SEA moves 31% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $519K — top 17 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Dushanbe is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 31% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$703K
45.8% of USD · 31.4% of ships
ICD
$463K
30.2% of USD · 19.0% of ships
AIR
$368K
24.0% of USD · 49.6% of ships
Fig 8.3 The dominant corridor is DELHI AIR → Air → Europe ($166K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Saudi Arabia is the most concentrated destination (HHI 10000, 1 suppliers). Philippines is the most competitive (HHI 3385).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Saudi Arabia (HHI 10,000) is the most concentrated — Philippines (HHI 3,385) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| DUSTI PHARM LLC | Tajikistan | EVOLET HEALTHCAR… | $154K | 3 | HIGH |
| PLANET PHARMA SA | France | GALPHA LABORATOR… | $114K | 2 | HIGH |
| M/S.AL MOATAMAD FOR … | Yemen | MANKIND PHARMA LTD | $94K | 1 | MEDIUM |
| KAMCARE PHARMA LTD | Kenya | CHETAN & DIPTI (… | $92K | 1 | MEDIUM |
| E P H K | Hungary | VENUS REMEDIES LTD | $83K | 2 | MEDIUM |
| BIOGLASS PHARMACEUTI… | Venezuela | ALDE MEDI IMPEX … | $58K | 11 | MEDIUM |
| TOROPH | Kazakhstan | BDR PHARMACEUTIC… | $52K | 1 | MEDIUM |
| DISPHARMA COTE DIVOIRE | Cote d'Ivoire | ATR PHARMA PVT LTD | $41K | 1 | MEDIUM |
Conclusion: 41 buyers depend on exactly one Indian supplier, representing $957K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Tajikistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Hungary | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| France | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Kazakhstan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Yemen | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Thailand | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Sudan | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Venezuela | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Afghanistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Cote d'Ivoire | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Latvia | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| China | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| South Africa | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 13 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Tajikistan | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Saudi Arabia lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter France (1 suppliers) | This Q | HIGH |
| A6 | Enter Kenya (2 suppliers) | This Q | MED |
| A8 | Build Hungary distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (GALPHA LABORATORIES) | This Q | MED |
| A7 | Register for Tajikistan tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | France | Other | 1 | $152K | +199.9% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Kenya | Africa | 2 | $165K | +3% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Hungary | Other | 1 | $166K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Kazakhstan | Asia | 1 | $103K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Yemen | Other | 1 | $94K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Thailand | Asia | 1 | $89K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Nigeria | Africa | 2 | $83K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Sudan | Africa | 3 | $80K | -99.3% | LOW | Low competition (3 suppliers), accessible market |
| 9 | Venezuela | Other | 2 | $59K | -98.5% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Afghanistan | Asia | 4 | $44K | 0% | LOW | Low competition (4 suppliers), accessible market |
| 11 | Cote d'Ivoire | Africa | 1 | $41K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Latvia | Other | 1 | $38K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | China | Asia | 1 | $30K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | South Africa | Africa | 1 | $28K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Cambodia | Asia | 2 | $28K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 121 2025-Q4 Ceftazidime shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/ceftazidime
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 121 2025-Q4 ceftazidime shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian ceftazidime shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
121
across all regions
TOTAL USD
$1.53M
2025-Q4 FOB value
UNITS
2.6M
tablets, capsules, etc.
SUPPLIERS
53
Indian exporters
BUYERS
45
global importers
COUNTRIES
41
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $413K (27.0%), spanning 13 countries.
53 Indian suppliers shipped to 45 buyers across 41 countries — average shipment value $13K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
13 countries · 37 shipments · $413K · 18 Indian suppliers · 13 buyers
SHIPMENTS
37
USD
$413K
COUNTRIES
13
SUPPLIERS
18
BUYERS
13
HHI
1,565
moderate
Top 13 destination countries in Africa
1
Kenya (39.9%)
$165K
2
Nigeria (20.1%)
$83K
3
Sudan (19.5%)
$80K
4
Cote d'Ivoire (9.9%)
$41K
5
South Africa (6.9%)
$28K
6
Libya (2.6%)
$11K
7
Angola (0.9%)
$4K
8
Liberia (0.1%)
$430.75
9
Mauritania (0.1%)
$345.82
10
DR Congo (0.1%)
$220.43
11
Somalia (0.0%)
$161.24
12
Morocco (0.0%)
$8.57
13
Mozambique (0.0%)
$0.327
Top 18 Indian suppliers into Africa
1
CHETAN & DIPTI (C&D) PHARMA PVT LTD
$92K
2
INJECT CARE PARENTERALS PVT LTD
$79K
3
THEON PHARMACEUTICALS LTD
$73K
4
FINECURE PHARMACEUTICALS LTD
$60K
5
ATR PHARMA PVT LTD
$41K
6
BIOMEDIC HEALTHCARE
$28K
7
PROTECH BIO SYSTEMS PVT LTD
$23K
8
AKUMS DRUGS AND PHARMACEUTICALS LTD
$11K
9
EXGEN CARE PVT LTD
$4K
10
BAKER & DAVIS PVT LTD
$1K
11
INNOVA CAPTAB LTD
$581.79
12
STARLITE INDUSTRIES PVT LTD
$430.75
13
NEU MICROMED INTERNATIONAL PVT LTD
$345.82
14
AURA PHARMACEUTICALS PVT LTD
$220.43
15
CURE EARTH PHARMA
$136.35
16
VEA IMPEX (I) PVT LTD
$24.90
17
VENUS REMEDIES LTD
$8.57
18
HSCC (INDIA) LTD
$0.327
Top 11 Africa importers
1
KAMCARE PHARMA LTD · Kenya
$92K
2
DISPHARMA COTE DIVOIRE · Cote d'Ivoire
$41K
3
RESMED HEALTHCARE · South Africa
$28K
4
CHINARE ANI PHARMACEUTICALS LTD · Nigeria
$12K
5
ATHAL INTERNATIONAL FOR PHARMACEUTI · Libya
$11K
6
QUEEENS ENTERPRISES CO LTD · Sudan
$1K
7
ELWALIEF INTERNATIONAL FOR MULTI · Sudan
$581.79
8
B-KAY, PHARMACY INC · Liberia
$430.75
9
KALKAAL HOSPITAL · Somalia
$136.35
10
PHARMAPROM · Morocco
$8.23
11
DR (MS.) LEIA MONTEIRO, DIRECTOR · Mozambique
$0.327
Top 5 dosage forms
1
Injection
$412K
2
Vial
$1K
3
powder for solution
$4.13
4
Powder
$4.10
5
Solution
$0.342
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 8 | $130K | $16K |
| Nov | 14 | $218K | $16K |
| Dec | 15 | $66K | $4K |
Shipment register · 37 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CHETAN & DIPTI (C&D) PHARMA PVT LTD · 1 shipments · $92K | |||||||||||
| 1 | Nov 2025 | KAMCARE PHARMA LTD | Kenya | Injection | 250.0K | NOS | $0.369 | $92K | MUNDRA SEA | Mombasa | SEA |
| SUPPLIER #2 — INJECT CARE PARENTERALS PVT LTD · 1 shipments · $79K | |||||||||||
| 2 | Oct 2025 | UNLISTED BUYER | Sudan | Injection | 142.1K | NOS | $0.555 | $79K | NHAVA SHEVA SEA (JNPT) | Port Sudan | SEA |
| SUPPLIER #3 — THEON PHARMACEUTICALS LTD · 6 shipments · $73K | |||||||||||
| 3 | Oct 2025 | UNLISTED BUYER | Kenya | Injection | 5.8K | NOS | $0.477 | $3K | CHAWAPAYAL ICD | MOMBASA | ICD |
| 4 | Oct 2025 | UNLISTED BUYER | Kenya | Injection | 42.5K | NOS | $0.477 | $20K | CHAWAPAYAL ICD | MOMBASA | ICD |
| 5 | Oct 2025 | UNLISTED BUYER | Kenya | Injection | 26.7K | NOS | $0.477 | $13K | CHAWAPAYAL ICD | MOMBASA | ICD |
| 6 | Dec 2025 | UNLISTED BUYER | Kenya | Injection | 25.3K | NOS | $0.491 | $12K | CHAWAPAYAL ICD | MOMBASA | ICD |
| 7 | Dec 2025 | UNLISTED BUYER | Kenya | Injection | 37.1K | NOS | $0.491 | $18K | CHAWAPAYAL ICD | MOMBASA | ICD |
| 8 | Dec 2025 | UNLISTED BUYER | Kenya | Injection | 12.6K | NOS | $0.491 | $6K | CHAWAPAYAL ICD | MOMBASA | ICD |
| SUPPLIER #4 — FINECURE PHARMACEUTICALS LTD · 1 shipments · $60K | |||||||||||
| 9 | Nov 2025 | UNLISTED BUYER | Nigeria | Injection | 93.6K | NOS | $0.642 | $60K | KASHIPUR ICD | APAPA | ICD |
| SUPPLIER #5 — ATR PHARMA PVT LTD · 1 shipments · $41K | |||||||||||
| 10 | Nov 2025 | DISPHARMA COTE DIVOIRE | Cote d'Ivoire | Injection | 50.0K | NOS | $0.816 | $41K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| SUPPLIER #6 — BIOMEDIC HEALTHCARE · 2 shipments · $28K | |||||||||||
| 11 | Dec 2025 | RESMED HEALTHCARE | South Africa | Injection | 44.6K | NOS | $0.636 | $28K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 12 | Dec 2025 | RESMED HEALTHCARE | South Africa | Injection | 1 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #7 — PROTECH BIO SYSTEMS PVT LTD · 2 shipments · $23K | |||||||||||
| 13 | Nov 2025 | CHINARE ANI PHARMACEUTICALS LTD | Nigeria | Injection | 25.0K | NOS | $0.460 | $12K | TUGHLAKABAD ICD | Apapa | ICD |
| 14 | Nov 2025 | UNKNOWN BUYER | Nigeria | Injection | 25.0K | NOS | $0.460 | $12K | TUGHLAKABAD ICD | Apapa | ICD |
| SUPPLIER #8 — AKUMS DRUGS AND PHARMACEUTICALS LTD · 1 shipments · $11K | |||||||||||
| 15 | Oct 2025 | ATHAL INTERNATIONAL FOR PHARMACEUTI | Libya | Injection | 9.5K | NOS | $1.14 | $11K | NHAVA SHEVA SEA (JNPT) | Tripoli | SEA |
| SUPPLIER #9 — EXGEN CARE PVT LTD · 1 shipments · $4K | |||||||||||
| 16 | Oct 2025 | UNLISTED BUYER | Angola | Injection | 8.0K | PCS | $0.466 | $4K | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| SUPPLIER #10 — BAKER & DAVIS PVT LTD · 3 shipments · $1K | |||||||||||
| 17 | Nov 2025 | QUEEENS ENTERPRISES CO LTD | Sudan | Vial | 70 | NOS | $0.569 | $39.83 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 18 | Nov 2025 | QUEEENS ENTERPRISES CO LTD | Sudan | Vial | 925 | NOS | $0.569 | $526.35 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 19 | Nov 2025 | QUEEENS ENTERPRISES CO LTD | Sudan | Vial | 1.0K | NOS | $0.489 | $489.17 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| SUPPLIER #11 — INNOVA CAPTAB LTD · 2 shipments · $581.79 | |||||||||||
| 20 | Dec 2025 | ELWALIEF INTERNATIONAL FOR MULTI | Sudan | Injection | 75.8K | NOS | $0.0065 | $490.00 | MUNDRA SEA | Port Sudan | SEA |
| 21 | Dec 2025 | ELWALIEF INTERNATIONAL FOR MULTI | Sudan | Injection | 14.2K | NOS | $0.0065 | $91.79 | MUNDRA SEA | Port Sudan | AIR |
| SUPPLIER #12 — STARLITE INDUSTRIES PVT LTD · 1 shipments · $430.75 | |||||||||||
| 22 | Nov 2025 | B-KAY, PHARMACY INC | Liberia | Injection | 480 | NOS | $0.897 | $430.75 | TUGHLAKABAD ICD | Monrovia | ICD |
| SUPPLIER #13 — NEU MICROMED INTERNATIONAL PVT LTD · 1 shipments · $345.82 | |||||||||||
| 23 | Oct 2025 | UNLISTED BUYER | Mauritania | Injection | 300 | NOS | $1.15 | $345.82 | AHMEDABAD AIR | NOUAKCHOTT | AIR |
| SUPPLIER #14 — AURA PHARMACEUTICALS PVT LTD · 1 shipments · $220.43 | |||||||||||
| 24 | Dec 2025 | UNKNOWN BUYER | DR Congo | Injection | 360 | NOS | $0.612 | $220.43 | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| SUPPLIER #15 — CURE EARTH PHARMA · 1 shipments · $136.35 | |||||||||||
| 25 | Oct 2025 | KALKAAL HOSPITAL | Somalia | Injection | 160 | NOS | $0.852 | $136.35 | CHENNAI AIR | MOGADISCHU | AIR |
| SUPPLIER #16 — VEA IMPEX (I) PVT LTD · 5 shipments · $24.90 | |||||||||||
| 26 | Dec 2025 | UNLISTED BUYER | Somalia | Injection | 422 | NOS | $0.0050 | $2.13 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 27 | Dec 2025 | UNLISTED BUYER | Somalia | Injection | 578 | NOS | $0.0050 | $2.92 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 28 | Dec 2025 | UNLISTED BUYER | Somalia | Vial | 1.0K | NOS | $0.0066 | $6.62 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 29 | Dec 2025 | UNLISTED BUYER | Somalia | Vial | 1.0K | NOS | $0.0066 | $6.62 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 30 | Dec 2025 | UNLISTED BUYER | Somalia | Vial | 1.0K | NOS | $0.0066 | $6.62 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #17 — VENUS REMEDIES LTD · 5 shipments · $8.57 | |||||||||||
| 31 | Nov 2025 | UNKNOWN BUYER | Morocco | Solution | 3 | NOS | $0.114 | $0.342 | DELHI AIR | CASABLANCA | AIR |
| 32 | Nov 2025 | PHARMAPROM | Morocco | Powder | 60 | NOS | $0.023 | $1.37 | DELHI AIR | CASABLANCA | AIR |
| 33 | Nov 2025 | PHARMAPROM | Morocco | Powder | 60 | NOS | $0.046 | $2.73 | DELHI AIR | CASABLANCA | AIR |
| 34 | Nov 2025 | PHARMAPROM | Morocco | powder for solution | 60 | NOS | $0.023 | $1.38 | DELHI AIR | CASABLANCA | AIR |
| 35 | Nov 2025 | PHARMAPROM | Morocco | powder for solution | 60 | NOS | $0.046 | $2.75 | DELHI AIR | CASABLANCA | AIR |
| SUPPLIER #18 — HSCC (INDIA) LTD · 2 shipments · $0.327 | |||||||||||
| 36 | Dec 2025 | DR (MS.) LEIA MONTEIRO, DIRECTOR | Mozambique | Injection | 1.4K | NOS | $0.0002 | $0.296 | MUNDRA SEA | Maputo | SEA |
| 37 | Dec 2025 | DR (MS.) LEIA MONTEIRO, DIRECTOR | Mozambique | Injection | 167 | NOS | $0.0002 | $0.031 | MUNDRA SEA | Maputo | SEA |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
14 countries · 48 shipments · $693K · 25 Indian suppliers · 23 buyers
SHIPMENTS
48
USD
$693K
COUNTRIES
14
SUPPLIERS
25
BUYERS
23
HHI
1,309
competitive
Top 14 destination countries in Asia
1
Tajikistan (34.5%)
$239K
2
Kazakhstan (14.9%)
$103K
3
Yemen (13.6%)
$94K
4
Thailand (12.9%)
$89K
5
Afghanistan (6.3%)
$44K
6
China (4.3%)
$30K
7
Cambodia (4.0%)
$28K
8
Philippines (3.0%)
$21K
9
Saudi Arabia (2.6%)
$18K
10
United Arab Emirates (2.4%)
$16K
11
Sri Lanka (0.7%)
$5K
12
Azerbaijan (0.7%)
$5K
13
Turkey (0.0%)
$51.39
14
Malaysia (0.0%)
$7.40
Top 25 Indian suppliers into Asia
1
EVOLET HEALTHCARE PVT LTD
$154K
2
MANKIND PHARMA LTD
$121K
3
BDR PHARMACEUTICALS INTERNATIONAL PVT LTD
$103K
4
SWISS PARENTERALS LTD
$89K
5
GOGA HEALTHCARE
$46K
6
UNITED BIOTECH PVT LTD
$37K
7
GRECIAN PVT LTD
$30K
8
IND SWIFT LABORATORIES LTD
$22K
9
VENUS REMEDIES LTD
$18K
10
HEAL REMEDICS PVT LTD
$17K
11
RMPL PHARMA LLP
$10K
12
ZYDUS LIFESCIENCES LTD
$8K
13
THEON PHARMACEUTICALS LTD
$8K
14
VHB MEDI SCIENCES LTD
$7K
15
PLICA VACCINES PVT LTD
$5K
16
SEATRACK INTERNATIONAL TRADEX PVT LTD
$4K
17
HEET HEALTHCARE PVT LTD
$3K
18
MODS DISPENSARY
$3K
19
HUMANKIND PHARMA
$2K
20
ZEE LABORATORIES LTD
$2K
21
LEOWIN HEALTHCARE LLP
$1K
22
LOB INTERNATIONAL
$51.39
23
THRIVE THERAPEUTIC PVT LTD
$49.41
24
BABA AGENCIES
$7.40
25
IND SWIFT LTD
$0.0000
Top 21 Asia importers
1
DUSTI PHARM LLC · Tajikistan
$154K
2
M/S.AL MOATAMAD FOR TRADING · Yemen
$94K
3
TOROPH · Kazakhstan
$52K
4
LIAONING SA · China
$30K
5
ZAHIR HADROGULL LTD · Afghanistan
$27K
6
LLC TIBBI OMEXTA · Tajikistan
$22K
7
LLC SHIFOI SINON. MAKHSUM STR DUSHA · Tajikistan
$17K
8
S T C · Saudi Arabia
$14K
9
RAOUFI GLOBAL GROUP COMPANY · Afghanistan
$8K
10
GREEN CORE PHARMA INC · Philippines
$8K
11
SAK CAM PHARMA CO LTD · Cambodia
$6K
12
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$6K
13
DELEX PHARMA INTERNATIONAL INC · Philippines
$6K
14
MASEEH AMIRZAI LTD · Afghanistan
$5K
15
KLINTAS PVT LTD · Sri Lanka
$5K
16
BRADY PHARMA INC · Philippines
$4K
17
NAME : AYGUN · Azerbaijan
$3K
18
MUSBAH TASNIM TRADING LTD · Afghanistan
$3K
19
ZEE HEALTHCARE CAMBODIA LTD · Cambodia
$2K
20
SCN ULUSLARARASI TASIMACILIK · Turkey
$51.39
21
VITAL RANK SDN BHD · Malaysia
$7.40
Top 10 dosage forms
1
Injection
$278K
2
Vial
$177K
3
Powder for Injection
$103K
4
Unknown
$94K
5
powder for solution for injection
$13K
6
Powder
$12K
7
powder for concentrate
$8K
8
Infusion
$4K
9
Other
$2K
10
powder for concentrate for infusion
$750.20
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 7 | $233K | $33K |
| Nov | 24 | $301K | $13K |
| Dec | 17 | $159K | $9K |
Shipment register · 48 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — EVOLET HEALTHCARE PVT LTD · 3 shipments · $154K | |||||||||||
| 1 | Oct 2025 | DUSTI PHARM LLC | Tajikistan | Vial | 151.3K | NOS | $0.478 | $72K | PIYALA ICD | Dushanbe | ICD |
| 2 | Oct 2025 | DUSTI PHARM LLC | Tajikistan | Vial | 29.5K | NOS | $0.307 | $9K | PIYALA ICD | Dushanbe | ICD |
| 3 | Oct 2025 | DUSTI PHARM LLC | Tajikistan | Vial | 151.3K | NOS | $0.478 | $72K | PIYALA ICD | Dushanbe | ICD |
| SUPPLIER #2 — MANKIND PHARMA LTD · 2 shipments · $121K | |||||||||||
| 4 | Nov 2025 | M/S.AL MOATAMAD FOR TRADING | Yemen | 316.1K | NOS | $0.299 | $94K | NHAVA SHEVA SEA (JNPT) | Aden | SEA | |
| 5 | Nov 2025 | ZAHIR HADROGULL LTD | Afghanistan | Injection | 100.0K | NOS | $0.270 | $27K | NHAVA SHEVA SEA (JNPT) | Kabul | SEA |
| SUPPLIER #3 — BDR PHARMACEUTICALS INTERNATIONAL PVT LTD · 2 shipments · $103K | |||||||||||
| 6 | Nov 2025 | TOROPH | Kazakhstan | Powder for Injection | 4.0K | VLS | $12.93 | $52K | MUMBAI AIR (SAHAR) | ALMATY | AIR |
| 7 | Nov 2025 | UNKNOWN BUYER | Kazakhstan | Powder for Injection | 4.0K | VLS | $12.93 | $52K | MUMBAI AIR (SAHAR) | ALMATY | AIR |
| SUPPLIER #4 — SWISS PARENTERALS LTD · 1 shipments · $89K | |||||||||||
| 8 | Dec 2025 | UNLISTED BUYER | Thailand | Injection | 206.1K | NOS | $0.433 | $89K | AHMEDABAD ICD | BANGKOK | ICD |
| SUPPLIER #5 — GOGA HEALTHCARE · 1 shipments · $46K | |||||||||||
| 9 | Oct 2025 | UNKNOWN BUYER | Tajikistan | Injection | 3.2K | KGS | $14.69 | $46K | MUNDRA SEA | KHUDZHAND | SEA |
| SUPPLIER #6 — UNITED BIOTECH PVT LTD · 4 shipments · $37K | |||||||||||
| 10 | Nov 2025 | SAK CAM PHARMA CO LTD | Cambodia | Injection | 10.0K | VLS | $0.649 | $6K | TUGHLAKABAD ICD | Sihanoukville (Kompo | ICD |
| 11 | Nov 2025 | DELEX PHARMA INTERNATIONAL INC | Philippines | Injection | 5.0K | NOS | $1.14 | $6K | DELHI AIR | MANILA | AIR |
| 12 | Dec 2025 | KLINTAS PVT LTD | Sri Lanka | Injection | 5.0K | NOS | $1.00 | $5K | DELHI AIR | COLOMBO | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | Cambodia | Injection | 30.0K | VLS | $0.648 | $19K | DELHI AIR | TECHO INTERNATIONAL | AIR |
| SUPPLIER #7 — GRECIAN PVT LTD · 1 shipments · $30K | |||||||||||
| 14 | Nov 2025 | LIAONING SA | China | Injection | 119.9K | PCS | $0.249 | $30K | SONEPAT ICD | DALIAN | ICD |
| SUPPLIER #8 — IND SWIFT LABORATORIES LTD · 2 shipments · $22K | |||||||||||
| 15 | Dec 2025 | LLC TIBBI OMEXTA | Tajikistan | Injection | 15.0K | NOS | $1.12 | $17K | DELHI AIR | DUSHANBE | AIR |
| 16 | Dec 2025 | LLC TIBBI OMEXTA | Tajikistan | Injection | 5.0K | NOS | $1.12 | $6K | DELHI AIR | DUSHANBE | AIR |
| SUPPLIER #9 — VENUS REMEDIES LTD · 6 shipments · $18K | |||||||||||
| 17 | Oct 2025 | S T C | Saudi Arabia | powder for solution for injection | 21.3K | VLS | $0.415 | $9K | DADRI ICD | DAMMAM | ICD |
| 18 | Nov 2025 | S T C | Saudi Arabia | Powder | 350 | VLS | $0.392 | $137.21 | CMA CGM LOGISTICS ICD | DAMMAM | ICD |
| 19 | Nov 2025 | S T C | Saudi Arabia | Powder | 10.0K | VLS | $0.408 | $4K | CMA CGM LOGISTICS ICD | DAMMAM | ICD |
| 20 | Nov 2025 | S T C | Saudi Arabia | Powder | 2.0K | VLS | $0.359 | $717.17 | CMA CGM LOGISTICS ICD | DAMMAM | ICD |
| 21 | Nov 2025 | UNKNOWN BUYER | Saudi Arabia | powder for solution for injection | 10.0K | VLS | $0.220 | $2K | DELHI AIR | RIYADH | AIR |
| 22 | Nov 2025 | UNKNOWN BUYER | Saudi Arabia | powder for solution for injection | 8.7K | VLS | $0.265 | $2K | DELHI AIR | RIYADH | AIR |
| SUPPLIER #10 — HEAL REMEDICS PVT LTD · 1 shipments · $17K | |||||||||||
| 23 | Oct 2025 | LLC SHIFOI SINON. MAKHSUM STR DUSHA | Tajikistan | Vial | 30.0K | PCS | $0.551 | $17K | NHAVA SHEVA SEA (JNPT) | Dushanbe | SEA |
| SUPPLIER #11 — RMPL PHARMA LLP · 3 shipments · $10K | |||||||||||
| 24 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Vial | 100 | NOS | $35.70 | $4K | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 25 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Vial | 100 | NOS | $35.70 | $4K | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 26 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 500 | NOS | $6.20 | $3K | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #12 — ZYDUS LIFESCIENCES LTD · 2 shipments · $8K | |||||||||||
| 27 | Dec 2025 | RAOUFI GLOBAL GROUP COMPANY | Afghanistan | powder for concentrate | 50 | NOS | $14.79 | $739.45 | DELHI AIR | KABUL | AIR |
| 28 | Dec 2025 | RAOUFI GLOBAL GROUP COMPANY | Afghanistan | powder for concentrate | 500 | NOS | $14.79 | $7K | DELHI AIR | KABUL | AIR |
| SUPPLIER #13 — THEON PHARMACEUTICALS LTD · 1 shipments · $8K | |||||||||||
| 29 | Oct 2025 | GREEN CORE PHARMA INC | Philippines | Injection | 10.0K | NOS | $0.760 | $8K | NHAVA SHEVA SEA (JNPT) | Manila South Harbour | SEA |
| SUPPLIER #14 — VHB MEDI SCIENCES LTD · 2 shipments · $7K | |||||||||||
| 30 | Nov 2025 | BRADY PHARMA INC | Philippines | Injection | 4.0K | VLS | $0.930 | $4K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 31 | Nov 2025 | UNKNOWN BUYER | Philippines | Injection | 4.0K | VLS | $0.930 | $4K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| SUPPLIER #15 — PLICA VACCINES PVT LTD · 2 shipments · $5K | |||||||||||
| 32 | Dec 2025 | MASEEH AMIRZAI LTD | Afghanistan | Powder | 13.8K | PCS | $0.388 | $5K | MUNDRA SEA | Kandahar | SEA |
| 33 | Dec 2025 | MASEEH AMIRZAI LTD | Afghanistan | Powder | 156 | PCS | $0.388 | $60.53 | MUNDRA SEA | Kandahar | SEA |
| SUPPLIER #16 — SEATRACK INTERNATIONAL TRADEX PVT LTD · 1 shipments · $4K | |||||||||||
| 34 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Infusion | 1.5K | NOS | $2.79 | $4K | DELHI AIR | DUBAI | AIR |
| SUPPLIER #17 — HEET HEALTHCARE PVT LTD · 2 shipments · $3K | |||||||||||
| 35 | Nov 2025 | NAME : AYGUN | Azerbaijan | Injection | 50 | NOS | $31.95 | $2K | MUMBAI AIR (SAHAR) | BAKU | AIR |
| 36 | Nov 2025 | NAME : AYGUN | Azerbaijan | Other | 50 | NOS | $35.96 | $2K | MUMBAI AIR (SAHAR) | BAKU | AIR |
| SUPPLIER #18 — MODS DISPENSARY · 1 shipments · $3K | |||||||||||
| 37 | Nov 2025 | MUSBAH TASNIM TRADING LTD | Afghanistan | Injection | 15.8K | PCS | $0.213 | $3K | TUGHLAKABAD ICD | Kabul | ICD |
| SUPPLIER #19 — HUMANKIND PHARMA · 4 shipments · $2K | |||||||||||
| 38 | Nov 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Injection | 199 | NOS | $0.928 | $184.75 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 39 | Nov 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Injection | 451 | NOS | $0.631 | $284.79 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 40 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Injection | 451 | NOS | $1.66 | $750.20 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 41 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | powder for concentrate for infusion | 451 | NOS | $1.66 | $750.20 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| SUPPLIER #20 — ZEE LABORATORIES LTD · 1 shipments · $2K | |||||||||||
| 42 | Nov 2025 | ZEE HEALTHCARE CAMBODIA LTD | Cambodia | Injection | 3.0K | PCS | $0.618 | $2K | SONEPAT ICD | PHNOM PENH | ICD |
| SUPPLIER #21 — LEOWIN HEALTHCARE LLP · 1 shipments · $1K | |||||||||||
| 43 | Nov 2025 | UNLISTED BUYER | Azerbaijan | Powder | 4 | NOS | $324.63 | $1K | MUMBAI AIR (SAHAR) | BAKU | AIR |
| SUPPLIER #22 — LOB INTERNATIONAL · 1 shipments · $51.39 | |||||||||||
| 44 | Dec 2025 | SCN ULUSLARARASI TASIMACILIK | Turkey | Injection | 18 | NOS | $2.85 | $51.39 | MUMBAI AIR (SAHAR) | ISTANBUL | AIR |
| SUPPLIER #23 — THRIVE THERAPEUTIC PVT LTD · 1 shipments · $49.41 | |||||||||||
| 45 | Dec 2025 | UNLISTED BUYER | Tajikistan | Injection | 7.9K | NOS | $0.0062 | $49.41 | MUNDRA SEA | Khudzhand | AIR |
| SUPPLIER #24 — BABA AGENCIES · 1 shipments · $7.40 | |||||||||||
| 46 | Nov 2025 | VITAL RANK SDN BHD | Malaysia | Injection | 25 | NOS | $0.296 | $7.40 | CHENNAI AIR | KUALA LUMPUR - INT'L | AIR |
| SUPPLIER #25 — IND SWIFT LTD · 2 shipments · $0.0000 | |||||||||||
| 47 | Dec 2025 | LLC TIBBI OMEXTA | Tajikistan | Injection | 15.0K | NOS | $0.0000 | $0.0000 | DELHI AIR | DUSHANBE | AIR |
| 48 | Dec 2025 | LLC TIBBI OMEXTA | Tajikistan | Injection | 5.0K | NOS | $0.0000 | $0.0000 | DELHI AIR | DUSHANBE | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
6 countries · 11 shipments · $365K · 5 Indian suppliers · 8 buyers
SHIPMENTS
11
USD
$365K
COUNTRIES
6
SUPPLIERS
5
BUYERS
8
HHI
3,932
concentrated
Top 6 destination countries in Europe
1
Hungary (45.6%)
$166K
2
France (41.7%)
$152K
3
Latvia (10.5%)
$38K
4
Albania (2.2%)
$8K
5
Greece (0.0%)
$96.84
6
Ukraine · Ukraine
$0.0000
Top 5 Indian suppliers into Europe
1
VENUS REMEDIES LTD
$166K
2
GALPHA LABORATORIES LTD
$152K
3
SANCE LABORATORIES PVT LTD
$38K
4
SWISS PARENTERALS LTD
$8K
5
ANANTA MEDICARE LTD
$0.0000
Top 6 Europe importers
1
PLANET PHARMA SA · France
$114K
2
E P H K · Hungary
$83K
3
SIA MAGNIPHARMA · Latvia
$38K
4
PLANET PHARMAZONE DACTIVITE DU GRA · France
$38K
5
QUALIMETRIX SA · Greece
$96.84
6
ANANTA MEDICARE UKRAINE LTD · Ukraine
$0.0000
Top 4 dosage forms
1
Injection
$198K
2
powder for solution for injection
$139K
3
powder_for_injection
$27K
4
Powder
$0.0000
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $76K | $38K |
| Nov | 5 | $166K | $33K |
| Dec | 4 | $122K | $31K |
Shipment register · 11 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — VENUS REMEDIES LTD · 5 shipments · $166K | |||||||||||
| 1 | Nov 2025 | E P H K | Hungary | powder for solution for injection | 35.1K | VLS | $1.60 | $56K | DELHI AIR | BUDAPEST, | AIR |
| 2 | Nov 2025 | E P H K | Hungary | powder_for_injection | 40.1K | VLS | $0.665 | $27K | DELHI AIR | BUDAPEST, | AIR |
| 3 | Nov 2025 | UNKNOWN BUYER | Hungary | powder for solution for injection | 35.1K | VLS | $1.60 | $56K | DELHI AIR | BUDAPEST, | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Hungary | powder for solution for injection | 40.1K | VLS | $0.665 | $27K | DELHI AIR | BUDAPEST, | AIR |
| 5 | Nov 2025 | QUALIMETRIX SA | Greece | Injection | 75 | NOS | $1.29 | $96.84 | DELHI AIR | ATHENS | AIR |
| SUPPLIER #2 — GALPHA LABORATORIES LTD · 3 shipments · $152K | |||||||||||
| 6 | Oct 2025 | PLANET PHARMAZONE DACTIVITE DU GRA | France | Injection | 10.0K | NOS | $3.78 | $38K | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
| 7 | Dec 2025 | PLANET PHARMA SA | France | Injection | 10.0K | NOS | $3.72 | $37K | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
| 8 | Dec 2025 | PLANET PHARMA SA | France | Injection | 20.0K | NOS | $3.83 | $77K | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
| SUPPLIER #3 — SANCE LABORATORIES PVT LTD · 1 shipments · $38K | |||||||||||
| 9 | Oct 2025 | SIA MAGNIPHARMA | Latvia | Injection | 42.8K | NOS | $0.892 | $38K | COCHIN SEA | Riga | SEA |
| SUPPLIER #4 — SWISS PARENTERALS LTD · 1 shipments · $8K | |||||||||||
| 10 | Dec 2025 | UNLISTED BUYER | Albania | Injection | 500 | NOS | $16.32 | $8K | AHMEDABAD ICD | DURRES | ICD |
| SUPPLIER #5 — ANANTA MEDICARE LTD · 1 shipments · $0.0000 | |||||||||||
| 11 | Dec 2025 | ANANTA MEDICARE UKRAINE LTD | Ukraine | Powder | 13.6K | VLS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Gdynia | SEA |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
7 countries · 24 shipments · $62K · 9 Indian suppliers · 7 buyers
SHIPMENTS
24
USD
$62K
COUNTRIES
7
SUPPLIERS
9
BUYERS
7
HHI
8,850
concentrated
Top 7 destination countries in Americas
1
Venezuela (95.5%)
$59K
2
Panama (2.4%)
$1K
3
Guyana (1.0%)
$650.39
4
Cayman Islands (1.0%)
$630.36
5
Antigua and Barbuda (0.0%)
$20.95
6
Jamaica (0.0%)
$18.00
7
Colombia (0.0%)
$7.48
Top 9 Indian suppliers into Americas
1
ALDE MEDI IMPEX LTD
$58K
2
VENUS REMEDIES LTD
$1K
3
EXQUISITE PHARMA LLP
$898.33
4
NARAYANA HRUDAYALAYA LTD
$606.26
5
PEAK HEALTHCARE
$534.48
6
NAMAN GLOBAL IMPEX PVT LTD
$115.91
7
MILES INTERNATIONAL
$24.10
8
3S PHARMACEUTICALS INDIA PVT LTD
$20.95
9
SHARVIK IMPEX (INDIA) PVT LTD
$18.00
Top 5 Americas importers
1
BIOGLASS PHARMACEUTICAL CASA DEREPR · Venezuela
$58K
2
U P G · Panama
$1K
3
HEALTH CITY CAYMAN ISLANDS (HCCI) · Cayman Islands
$606.26
4
FOR THE ORDER OF · Antigua and Barbuda
$20.95
5
JOAN DAVIS · Jamaica
$18.00
Top 5 dosage forms
1
Solution
$35K
2
Powder
$23K
3
powder for solution
$1K
4
Injection
$1K
5
Vial
$898.33
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 11 | $58K | $5K |
| Nov | 1 | $598.97 | $598.97 |
| Dec | 12 | $3K | $259.08 |
Shipment register · 24 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ALDE MEDI IMPEX LTD · 11 shipments · $58K | |||||||||||
| 1 | Oct 2025 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | Powder | 98.8K | NOS | $0.236 | $23K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 2 | Oct 2025 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | Powder | 344 | NOS | $0.236 | $81.12 | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 3 | Oct 2025 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | Solution | 9.0K | NOS | $0.555 | $5K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 4 | Oct 2025 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | Solution | 75 | NOS | $1.39 | $104.04 | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 5 | Oct 2025 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | Solution | 2.9K | NOS | $1.09 | $3K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 6 | Oct 2025 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | Solution | 70 | NOS | $1.39 | $97.11 | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 7 | Oct 2025 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | Solution | 14.0K | NOS | $0.654 | $9K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 8 | Oct 2025 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | Solution | 6.8K | NOS | $1.39 | $9K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 9 | Oct 2025 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | Solution | 15.0K | NOS | $0.535 | $8K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 10 | Oct 2025 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | Solution | 30 | NOS | $0.654 | $19.61 | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 11 | Oct 2025 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | Powder | 200 | NOS | $0.236 | $47.17 | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| SUPPLIER #2 — VENUS REMEDIES LTD · 1 shipments · $1K | |||||||||||
| 12 | Dec 2025 | U P G | Panama | powder for solution | 220 | NOS | $6.77 | $1K | DELHI AIR | PANAMA CITY - | AIR |
| SUPPLIER #3 — EXQUISITE PHARMA LLP · 3 shipments · $898.33 | |||||||||||
| 13 | Dec 2025 | UNLISTED BUYER | Colombia | Vial | 100 | PCS | $0.075 | $7.48 | MUMBAI AIR (SAHAR) | BOGOTA | AIR |
| 14 | Dec 2025 | UNLISTED BUYER | Venezuela | Vial | 50 | PCS | $8.91 | $445.65 | MUMBAI AIR (SAHAR) | CARACAS | AIR |
| 15 | Dec 2025 | UNLISTED BUYER | Venezuela | Vial | 50 | PCS | $8.90 | $445.20 | MUMBAI AIR (SAHAR) | CARACAS | AIR |
| SUPPLIER #4 — NARAYANA HRUDAYALAYA LTD · 2 shipments · $606.26 | |||||||||||
| 16 | Nov 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Injection | 150 | NOS | $3.99 | $598.97 | BANGALORE AIR | GEORGETOWN | AIR |
| 17 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Injection | 160 | NOS | $0.046 | $7.29 | BANGALORE AIR | GEORGETOWN | AIR |
| SUPPLIER #5 — PEAK HEALTHCARE · 3 shipments · $534.48 | |||||||||||
| 18 | Dec 2025 | UNLISTED BUYER | Guyana | Injection | 150 | NOS | $1.78 | $267.32 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 19 | Dec 2025 | UNLISTED BUYER | Guyana | Injection | 150 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 20 | Dec 2025 | UNLISTED BUYER | Guyana | Injection | 150 | NOS | $1.78 | $267.16 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| SUPPLIER #6 — NAMAN GLOBAL IMPEX PVT LTD · 1 shipments · $115.91 | |||||||||||
| 21 | Dec 2025 | UNKNOWN BUYER | Guyana | Injection | 60 | NOS | $1.93 | $115.91 | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
| SUPPLIER #7 — MILES INTERNATIONAL · 1 shipments · $24.10 | |||||||||||
| 22 | Dec 2025 | UNLISTED BUYER | Cayman Islands | Injection | 40 | VLS | $0.602 | $24.10 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| SUPPLIER #8 — 3S PHARMACEUTICALS INDIA PVT LTD · 1 shipments · $20.95 | |||||||||||
| 23 | Dec 2025 | FOR THE ORDER OF | Antigua and Barbuda | Injection | 50 | VLS | $0.419 | $20.95 | MUMBAI AIR (SAHAR) | ANTIGUA | AIR |
| SUPPLIER #9 — SHARVIK IMPEX (INDIA) PVT LTD · 1 shipments · $18.00 | |||||||||||
| 24 | Dec 2025 | JOAN DAVIS | Jamaica | Injection | 12 | NOS | $1.50 | $18.00 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $1K · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$1K
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Papua New Guinea (100.0%)
$1K
Top 1 Indian suppliers into Oceania
1
CHOUDHARI IMPEX
$1K
Top 0 Oceania importers
Top 1 dosage forms
1
Tablet
$1K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 1 | $1K | $1K |
| Dec | 0 | $0.0000 | — |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CHOUDHARI IMPEX · 1 shipments · $1K | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | Papua New Guinea | Tablet | 2.6K | NOS | $0.429 | $1K | CHENNAI SEA | Port Moresby | SEA |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 53 Indian ceftazidime exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped ceftazidime in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | VENUS REMEDIES LTD | BEHRA | 17 | $186K | powder for solution for injection, Powder, powder_for_injection | Asia, Europe |
| 2 | EVOLET HEALTHCARE PVT LTD | GURGRAM | 3 | $154K | Vial | Asia |
| 3 | GALPHA LABORATORIES LTD | PATNA | 3 | $152K | Injection | Europe |
| 4 | MANKIND PHARMA LTD | Farrukhnagar | 2 | $121K | Injection | Asia |
| 5 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | MUMBAI | 2 | $103K | Powder for Injection | Asia |
| 6 | SWISS PARENTERALS LTD | AHMEDABAD | 2 | $97K | Injection | Europe, Asia |
| 7 | CHETAN & DIPTI (C&D) PHARMA PVT LTD | MANDVI | 1 | $92K | Injection | Africa |
| 8 | THEON PHARMACEUTICALS LTD | DISTT SOLAN HP | 7 | $80K | Injection | Africa, Asia |
| 9 | INJECT CARE PARENTERALS PVT LTD | AHMEDABAD/GUJARAT | 1 | $79K | Injection | Africa |
| 10 | FINECURE PHARMACEUTICALS LTD | NAGAR RUDRAPUR | 1 | $60K | Injection | Africa |
| 11 | ALDE MEDI IMPEX LTD | New Delhi | 11 | $58K | Powder, Solution | Americas |
| 12 | GOGA HEALTHCARE | SURAT | 1 | $46K | Injection | Asia |
| 13 | ATR PHARMA PVT LTD | DEHRADUN | 1 | $41K | Injection | Africa |
| 14 | SANCE LABORATORIES PVT LTD | PALA | 1 | $38K | Injection | Europe |
| 15 | UNITED BIOTECH PVT LTD | NEW DELHI | 4 | $37K | Injection | Asia |
| 16 | GRECIAN PVT LTD | NEW DELHI | 1 | $30K | Injection | Asia |
| 17 | BIOMEDIC HEALTHCARE | MUMBAI | 2 | $28K | Injection | Africa |
| 18 | PROTECH BIO SYSTEMS PVT LTD | GURUGRAM | 2 | $23K | Injection | Africa |
| 19 | IND SWIFT LABORATORIES LTD | SAMBA JAMMU | 2 | $22K | Injection | Asia |
| 20 | HEAL REMEDICS PVT LTD | LUCKNOW U.P. | 1 | $17K | Vial | Asia |
| 21 | AKUMS DRUGS AND PHARMACEUTICALS LTD | DELHI | 1 | $11K | Injection | Africa |
| 22 | RMPL PHARMA LLP | MUMBAI | 3 | $10K | Vial, Injection | Asia |
| 23 | ZYDUS LIFESCIENCES LTD | AHMEDABAD | 2 | $8K | powder for concentrate | Asia |
| 24 | VHB MEDI SCIENCES LTD | UDHAMSINGH NAGAR | 2 | $7K | Injection | Asia |
| 25 | PLICA VACCINES PVT LTD | Ghaziabad | 2 | $5K | Powder | Asia |
| 26 | SEATRACK INTERNATIONAL TRADEX PVT LTD | NEW DELHI | 1 | $4K | Infusion | Asia |
| 27 | EXGEN CARE PVT LTD | NOIDA | 1 | $4K | Injection | Africa |
| 28 | HEET HEALTHCARE PVT LTD | AHMEDABAD | 2 | $3K | Injection, Other | Asia |
| 29 | MODS DISPENSARY | DEHRADUN | 1 | $3K | Injection | Asia |
| 30 | HUMANKIND PHARMA | Mumbai | 4 | $2K | Injection, powder for concentrate for infusion | Asia |
| 31 | ZEE LABORATORIES LTD | HARYANA | 1 | $2K | Injection | Asia |
| 32 | LEOWIN HEALTHCARE LLP | GANDHINAGAR | 1 | $1K | Powder | Asia |
| 33 | CHOUDHARI IMPEX | CHENNAI | 1 | $1K | Tablet | Oceania |
| 34 | BAKER & DAVIS PVT LTD | MUMBAI | 3 | $1K | Vial | Africa |
| 35 | EXQUISITE PHARMA LLP | Mumbai | 3 | $898.33 | Vial | Americas |
| 36 | NARAYANA HRUDAYALAYA LTD | BANGALORE | 2 | $606.26 | Injection | Americas |
| 37 | INNOVA CAPTAB LTD | BADDI | 2 | $581.79 | Injection | Africa |
| 38 | PEAK HEALTHCARE | MUMBAI | 3 | $534.48 | Injection | Americas |
| 39 | STARLITE INDUSTRIES PVT LTD | DELHI | 1 | $430.75 | Injection | Africa |
| 40 | NEU MICROMED INTERNATIONAL PVT LTD | KALOL | 1 | $345.82 | Injection | Africa |
| 41 | AURA PHARMACEUTICALS PVT LTD | BORIVALI EAST | 1 | $220.43 | Injection | Africa |
| 42 | CURE EARTH PHARMA | Chennai | 1 | $136.35 | Injection | Africa |
| 43 | NAMAN GLOBAL IMPEX PVT LTD | MUMBAI | 1 | $115.91 | Injection | Americas |
| 44 | LOB INTERNATIONAL | MUMBAI | 1 | $51.39 | Injection | Asia |
| 45 | THRIVE THERAPEUTIC PVT LTD | THANE | 1 | $49.41 | Injection | Asia |
| 46 | VEA IMPEX (I) PVT LTD | MUMBAI | 5 | $24.90 | Injection, Vial | Africa |
| 47 | MILES INTERNATIONAL | MUMBAI | 1 | $24.10 | Injection | Americas |
| 48 | 3S PHARMACEUTICALS INDIA PVT LTD | MUMBAI | 1 | $20.95 | Injection | Americas |
| 49 | SHARVIK IMPEX (INDIA) PVT LTD | NAGPUR (M.S.) | 1 | $18.00 | Injection | Americas |
| 50 | BABA AGENCIES | Chennai | 1 | $7.40 | Injection | Asia |
| 51 | HSCC (INDIA) LTD | NOIDA | 2 | $0.327 | Injection | Africa |
| 52 | ANANTA MEDICARE LTD | SRI GANGANAGAR | 1 | $0.0000 | Powder | Europe |
| 53 | IND SWIFT LTD | JAMMU | 2 | $0.0000 | Injection | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 43 global ceftazidime importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian ceftazidime in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | DUSTI PHARM LLC | Tajikistan | 3 | $154K | EVOLET HEALTHCARE PV… | Vial |
| 2 | PLANET PHARMA SA | France | 2 | $114K | GALPHA LABORATORIES … | Injection |
| 3 | M/S.AL MOATAMAD FOR TRADING | Yemen | 1 | $94K | MANKIND PHARMA LTD | |
| 4 | KAMCARE PHARMA LTD | Kenya | 1 | $92K | CHETAN & DIPTI (C&D)… | Injection |
| 5 | E P H K | Hungary | 2 | $83K | VENUS REMEDIES LTD | powder for solution for injection, powder_for_injection |
| 6 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | 11 | $58K | ALDE MEDI IMPEX LTD | Powder, Solution |
| 7 | TOROPH | Kazakhstan | 1 | $52K | BDR PHARMACEUTICALS … | Powder for Injection |
| 8 | DISPHARMA COTE DIVOIRE | Cote d'Ivoire | 1 | $41K | ATR PHARMA PVT LTD | Injection |
| 9 | SIA MAGNIPHARMA | Latvia | 1 | $38K | SANCE LABORATORIES P… | Injection |
| 10 | PLANET PHARMAZONE DACTIVITE DU GRA | France | 1 | $38K | GALPHA LABORATORIES … | Injection |
| 11 | LIAONING SA | China | 1 | $30K | GRECIAN PVT LTD | Injection |
| 12 | RESMED HEALTHCARE | South Africa | 2 | $28K | BIOMEDIC HEALTHCARE | Injection |
| 13 | ZAHIR HADROGULL LTD | Afghanistan | 1 | $27K | MANKIND PHARMA LTD | Injection |
| 14 | LLC TIBBI OMEXTA | Tajikistan | 4 | $22K | IND SWIFT LABORATORI… | Injection |
| 15 | LLC SHIFOI SINON. MAKHSUM STR DUSHA | Tajikistan | 1 | $17K | HEAL REMEDICS PVT LTD | Vial |
| 16 | S T C | Saudi Arabia | 4 | $14K | VENUS REMEDIES LTD | powder for solution for injection, Powder |
| 17 | CHINARE ANI PHARMACEUTICALS LTD | Nigeria | 1 | $12K | PROTECH BIO SYSTEMS … | Injection |
| 18 | ATHAL INTERNATIONAL FOR PHARMACEUTI | Libya | 1 | $11K | AKUMS DRUGS AND PHAR… | Injection |
| 19 | RAOUFI GLOBAL GROUP COMPANY | Afghanistan | 2 | $8K | ZYDUS LIFESCIENCES LTD | powder for concentrate |
| 20 | GREEN CORE PHARMA INC | Philippines | 1 | $8K | THEON PHARMACEUTICAL… | Injection |
| 21 | SAK CAM PHARMA CO LTD | Cambodia | 1 | $6K | UNITED BIOTECH PVT LTD | Injection |
| 22 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 5 | $6K | SEATRACK INTERNATION… | Injection, powder for concentrate for infusion, Infusion |
| 23 | DELEX PHARMA INTERNATIONAL INC | Philippines | 1 | $6K | UNITED BIOTECH PVT LTD | Injection |
| 24 | MASEEH AMIRZAI LTD | Afghanistan | 2 | $5K | PLICA VACCINES PVT LTD | Powder |
| 25 | KLINTAS PVT LTD | Sri Lanka | 1 | $5K | UNITED BIOTECH PVT LTD | Injection |
| 26 | BRADY PHARMA INC | Philippines | 1 | $4K | VHB MEDI SCIENCES LTD | Injection |
| 27 | NAME : AYGUN | Azerbaijan | 2 | $3K | HEET HEALTHCARE PVT … | Injection, Other |
| 28 | MUSBAH TASNIM TRADING LTD | Afghanistan | 1 | $3K | MODS DISPENSARY | Injection |
| 29 | ZEE HEALTHCARE CAMBODIA LTD | Cambodia | 1 | $2K | ZEE LABORATORIES LTD | Injection |
| 30 | U P G | Panama | 1 | $1K | VENUS REMEDIES LTD | powder for solution |
| 31 | QUEEENS ENTERPRISES CO LTD | Sudan | 3 | $1K | BAKER & DAVIS PVT LTD | Vial |
| 32 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | 2 | $606.26 | NARAYANA HRUDAYALAYA… | Injection |
| 33 | ELWALIEF INTERNATIONAL FOR MULTI | Sudan | 2 | $581.79 | INNOVA CAPTAB LTD | Injection |
| 34 | B-KAY, PHARMACY INC | Liberia | 1 | $430.75 | STARLITE INDUSTRIES … | Injection |
| 35 | KALKAAL HOSPITAL | Somalia | 1 | $136.35 | CURE EARTH PHARMA | Injection |
| 36 | QUALIMETRIX SA | Greece | 1 | $96.84 | VENUS REMEDIES LTD | Injection |
| 37 | SCN ULUSLARARASI TASIMACILIK | Turkey | 1 | $51.39 | LOB INTERNATIONAL | Injection |
| 38 | FOR THE ORDER OF | Antigua and Barbuda | 1 | $20.95 | 3S PHARMACEUTICALS I… | Injection |
| 39 | JOAN DAVIS | Jamaica | 1 | $18.00 | SHARVIK IMPEX (INDIA… | Injection |
| 40 | PHARMAPROM | Morocco | 4 | $8.23 | VENUS REMEDIES LTD | Powder, powder for solution |
| 41 | VITAL RANK SDN BHD | Malaysia | 1 | $7.40 | BABA AGENCIES | Injection |
| 42 | DR (MS.) LEIA MONTEIRO, DIRECTOR | Mozambique | 2 | $0.327 | HSCC (INDIA) LTD | Injection |
| 43 | ANANTA MEDICARE UKRAINE LTD | Ukraine | 1 | $0.0000 | ANANTA MEDICARE LTD | Powder |
This report covers 121 2025-Q4 Ceftazidime shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/ceftazidime
Talk to our trade analyst
Need a custom ceftazidime report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/ceftazidime
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Ceftazidime product page
Live data, supplier directory, price trends, and trade route analysis